Vectorite Biomedical Inc. (TPEX:4170)
Taiwan · Delayed Price · Currency is TWD 12.60
-0.05 (-0.40%)
Jun 18, 2026, 2:39 PM CST
Vectorite Biomedical Market Cap
Vectorite Biomedical has a market cap or net worth of 551.52 million as of June 18, 2026. Its market cap has decreased by -3.08% in one year.
Market Cap
551.52M
Enterprise Value
381.66M
Revenue
61.41M
Ranking
n/a
PE Ratio
5.75
Stock Price
12.60
Market Cap Chart
Since April 15, 2013, Vectorite Biomedical's market cap has increased from 393.23M to 551.52M, an increase of 40.25%. That is a compound annual growth rate of 2.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 551.52M | -10.00% |
| Dec 31, 2025 | 612.80M | -3.45% |
| Dec 31, 2024 | 634.68M | -32.08% |
| Dec 29, 2023 | 934.52M | 49.34% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| U-Neuron Biomedical | 955.94M |
| Meribank Biotech | 954.00M |
| Taiwan Advance Bio-Pharmaceutical | 949.50M |
| TCI GENE | 944.57M |
| NatureWise Biotech & Medicals | 855.45M |
| MegaPro Biomedical | 802.54M |
| Neith | 791.43M |
| BioLASCO Taiwan | 777.32M |